120 related articles for article (PubMed ID: 2035426)
1. Does intravenous milrinone have a direct effect on diastolic function?
Krams R; McFalls E; van der Giessen WJ; Serruys PW; Verdoun PD; Roelandt J
Am Heart J; 1991 Jun; 121(6 Pt 2):1951-5. PubMed ID: 2035426
[TBL] [Abstract][Full Text] [Related]
2. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
4. Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heart.
Piscione F; Jaski BE; Wenting GJ; Serruys PW
J Am Coll Cardiol; 1987 Dec; 10(6):1294-302. PubMed ID: 3680800
[TBL] [Abstract][Full Text] [Related]
5. Effects of phosphodiesterase III inhibition on length-dependent regulation of myocardial function in coronary surgery patients.
De Hert SG; ten Broecke PW; Mertens E; Rodrigus IE; Stockman BA
Br J Anaesth; 2002 Jun; 88(6):779-84. PubMed ID: 12173193
[TBL] [Abstract][Full Text] [Related]
6. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
7. Milrinone versus dobutamine: contribution of altered myocardial mechanics and augmented inotropic state to improved left ventricular performance.
Borow KM; Neumann A; Lang RM
Circulation; 1986 Mar; 73(3 Pt 2):III153-61. PubMed ID: 3943179
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
Al-Wathiqui MH; Shimshak TM; Brooks HL; Preuss KC; Wynsen JC; Gross GJ; Warltier DC
Pharmacology; 1988; 36(4):217-27. PubMed ID: 3380877
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship.
Murakami R; Sano K; Murakami Y; Shimada T; Morioka S
Int J Cardiol; 1995 Aug; 51(1):57-63. PubMed ID: 8522398
[TBL] [Abstract][Full Text] [Related]
10. The use of intravenous milrinone in chronic symptomatic ischemic heart disease.
Mitrovic V; Stöhring R; Schlepper M
Am Heart J; 1991 Jun; 121(6 Pt 2):1983-94. PubMed ID: 1827940
[TBL] [Abstract][Full Text] [Related]
11. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
[TBL] [Abstract][Full Text] [Related]
12. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
Young RA; Ward A
Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
[TBL] [Abstract][Full Text] [Related]
13. Effects of milrinone and sulmazole on left ventricular mechanoenergetics in canine hearts.
Hata K; Goto Y; Futaki S; Takasago T; Saeki A; Nishioka T; Suga H
J Card Fail; 1996 Sep; 2(3):203-13. PubMed ID: 8891859
[TBL] [Abstract][Full Text] [Related]
14. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass.
Kikura M; Levy JH; Michelsen LG; Shanewise JS; Bailey JM; Sadel SM; Szlam F
Anesth Analg; 1997 Jul; 85(1):16-22. PubMed ID: 9212116
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of intravenous milrinone in heart failure.
Rettig GF; Schieffer HJ
Eur Heart J; 1989 Aug; 10 Suppl C():39-43. PubMed ID: 2680496
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of milrinone.
Colucci WS
Am Heart J; 1991 Jun; 121(6 Pt 2):1945-7. PubMed ID: 2035424
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy.
Brecker SJ; Xiao HB; Mbaissouroum M; Gibson DG
Am J Cardiol; 1993 Jan; 71(2):203-9. PubMed ID: 8421984
[TBL] [Abstract][Full Text] [Related]
18. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
[TBL] [Abstract][Full Text] [Related]
20. Short-term assessment of left ventricular function, coronary hemodynamics, and catecholamine balance in severe congestive heart failure after a single oral dose of milrinone.
Piscione F; Jaski BE; Serruys PW
J Cardiovasc Pharmacol; 1988 Mar; 11(3):258-69. PubMed ID: 2452918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
